Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07324486 for Total Knee Arthroplasty, Adductor Canal Block, Genicular Nerves Block, IPACK Block Multimodal Analgesia is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Postoperative Analgesic Efficacy Between Adductor Canal Block + IPACK Block and Adductor Canal Block + Genicular Nerve Block in Total Knee Arthroplasty 50
Clinical Trial NCT07324486 is an interventional study for Total Knee Arthroplasty, Adductor Canal Block, Genicular Nerves Block, IPACK Block Multimodal Analgesia and is currently not yet recruiting. Enrollment is planned to begin on 15 December 2025 and continue until the study accrues 50 participants. Led by Konya Beyhekim Training and Research Hospital, this study is expected to complete by 1 February 2026. The latest data from ClinicalTrials.gov was last updated on 7 January 2026.
Brief Summary
The aim of this study is to compare the postoperative analgesic efficacy and functional outcomes of the IPACK+Adductor Canal Block with the Genicular Nerve Block+Adductor Canal Block block in patients undergoing total knee arthroplasty (TKA). The primary objective (measurable) is to evaluate functional improvement using 6-Clicks scores, while secondary objectives include pain scores (Vas Score), opioid consumption, h...Show More
Detailed Description
Group I: Patients who underwent IPACK + Adductor canal block after TDA surgery Group G: Patients who underwent Genicular nerve block + Adductor canal block after TDA surgery
This study will be designed as a prospective randomized trial, and randomization will be performed using the sealed envelope method. This method will be carried out as follows:
First, the study will include two groups: Group I (patients who rec...
Show MoreOfficial Title
Comparison of Functional Outcomes and Postoperative Analgesic Efficacy Between Adductor Canal Block + IPACK Block and Adductor Canal Block + Genicular Nerve Block in Patients Undergoing Total Knee Arthroplasty
Conditions
Total Knee ArthroplastyAdductor Canal BlockGenicular Nerves BlockIPACK Block Multimodal AnalgesiaOther Study IDs
- KonyaBeyhekimTRH2025/0115
NCT ID Number
Start Date (Actual)
2025-12-15
Last Update Posted
2026-01-07
Completion Date (Estimated)
2026-02-01
Enrollment (Estimated)
50
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
total knee arthroplasty
adductor canal block
genicular nerves block
IPACK
adductor canal block
genicular nerves block
IPACK
Primary Purpose
Treatment
Design Allocation
Randomized
Interventional Model
Parallel
Masking
Double
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
OtherGROUP IPACK ADDUCTOR CANAL BLOCK + IPACK | Adductor Canal Block (ACB) + iPACK Block Patients who underwent total knee arthroplasty surgery with IPACK + adductor canal block , 25 patients. After the needle tip is placed in the target area between the popliteal artery and the femur, the local anesthetic solution (10 ml of 0.5% bupivacaine + 10 ml of physiological saline) is slowly injected after negative aspiration. After the needle tip is placed within the adductor canal, the local anesthetic solutio...Show More |
ExperimentalGROUP GENİCULAR ADDUCTOR CANAL BLOCK + GENİCULAR BLOCK | adductor canal block + genicular blocks Patients who underwent total knee arthroplasty surgery with genicular blocks + adductor canal block , 25 patients. The tip of the needle is directed toward the superior lateral, superior medial, and inferior medial genicular nerves under ultrasound guidance.2 ml of local anesthetic (0.5% bupivacaine) is injected into each nerve region. After the needle tip is placed into the adductor canal, the local anesthetic solut...Show More |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
6-Clicks score | Known as "6-Clicks" due to being composed of six scored patient activity questions, a patient's "6-Clicks" score falls on a 6- to 24-point scale where a score of 6 represents total functional impairment and a score of 24 represents total absence of impairment. | 6.,12.,24.,36.,48.,60.,72. hours |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
visual analog scale | The Visual Analogue Scale (VAS) is a psychometric instrument used in research and clinical studies to measure the intensity of subjective experiences that cannot be objectively quantified using defined biomarkers, such as pain, fatigue, or mood. It typically consists of a 100 mm straight line with descriptive anchors at each end representing the extremes of the sensation (for example, "no pain" at one end and "the most severe pain imaginable" at the other). | Postoperative recovery room 30 minutes and at 6., 12., 24., 36., 48., 60., and 72. hours |
total opioid consumption | total opioid consumption per day | total opioid consumption 24.hour |
The Patient Satisfaction Index | The Patient Satisfaction Index (PSI) was used to describe self-evaluation of the outcome and responseof 1 or 2 was considered to indicate a satisfying outcomeand 3 or 4 to indicate a dissatisfied outcome. | first 24. hour |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- Patients scheduled for spinal anesthesia with TDA.
- Age ≥18.
- American Society of Anesthesiologists (ASA) physical status score I-III.
- Patients capable of providing informed consent.
- Active infection at the injection site.
- Coagulopathy or systemic sepsis.
- Severe hypovolemia.
- Patients who refuse regional anesthesia.
- Known allergy to local anesthetics.
- Cognitive impairment or uncooperative patients.
Study Responsible Party
Sami Uyar, Principal Investigator, Dr., Konya Beyhekim Training and Research Hospital
Study Central Contact
Contact: Sami Uyar, Dr, +905379869085, [email protected]
No location data.